Progranulin protects against cerebral ischemia-reperfusion (I/R) injury by inhibiting necroptosis and oxidative stress
Xiaogang Li 1 , Shaoli Cheng 2 , Hao Hu 2 , Xiaotian Zhang 3 , Jiehua Xu 3 , Rui Wang 1 , Pengbo Zhang 4 Affiliations
- PMID: 31679689
- DOI: 10.1016/j.bbrc.2019.09.111
- Corrigendum to “Progranulin protects against cerebral ischemia-reperfusion (I/R) injury by inhibiting necroptosis and oxidative stress” [Biochem. Biophys. Res. Commun. 521 (315) (2020) 569-576]. Li X, Cheng S, HaoHu, Zhang X, JiehuaXu, Wang R, Zhang P. Biochem Biophys Res Commun. 2020 May 7;525(3):822. doi: 10.1016/j.bbrc.2020.03.001. Epub 2020 Mar 11. PMID: 32171520 No abstract available.
Ischemic stroke is a leading cause of mortality and disability worldwide. Nevertheless, its molecular mechanisms have not yet been adequately illustrated. Progranulin (PGRN) is a secreted glycoprotein with pleiotropic functions. In the present study, we found that PGRN expression was markedly reduced in mice after stroke onset through middle cerebral artery occlusion (MCAO). We also showed that necroptosis was a mechanism underlying cerebral I/R injury. Importantly, PGRN knockdown in vivo significantly promoted the infarction volume and neurological deficits scores in mice after MCAO surgery. Necroptosis induced by MCAO was further accelerated by PGRN knockdown, as evidenced by the promoted expression of phosphorylated receptor-interacting protein (RIP) 1 kinase (RIPK1), RIPK3 and mixed lineage kinase domain-like (MLKL), which was accompanied with increased expression of cleaved Caspase-8 and Caspase-3. However, PGRN over-expression was neuroprotective. Additionally, PGRN-regulated ischemic stroke was related to ROS accumulation that MCAO-mice with PGRN knockdown exhibited severe oxidative stress, as proved by the aggravated malondialdehyde (MDA) and lipid peroxidation (LPO) contents, and the decreased superoxide dismutase (SOD) activity. However, PGRN over-expression in mice with cerebral ischemia showed anti-oxidative effects. Finally, PGRN was found to attenuate oxidative damage partly via its regulatory effects on necroptosis. Therefore, promoting PGRN expression could reduced cerebral I/R-induced brain injury by suppressing neroptosis and associated reactive oxygen species (ROS) production. These data elucidated that PGRN might provide an effective therapeutic treatment for ischemic stroke.
Keywords: Ischemic stroke; Necroptosis; PGRN; ROS.